Capybara Research said in a recently published report that it sees “problems at Nutex.” “Over a dozen Nutex partners, including physicians, medical directors, and board members, have accused Nutex and its CEO and Chairman, Thomas Vo of wrongdoing including fraud, embezzlement, and self-dealing. The allegations are corroborated by multiple independent sources including former insiders with first-hand knowledge. The allegations are also consistent over time, showing a pattern of misconduct spanning over 10 years… Nutex’s reputation is catching up with it and partners are fighting back. We believe it’s only a matter of time before more physician groups and ERs part ways with the company, causing others to follow their lead,” the report reads. Overall, Capybara says that, “after extensive research including interviews with former insiders and partners, we believe that Nutex Health (NUTX) and its founder CEO have engaged in a pattern of fraudulent and unethical business practices.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUTX:
